| LINE ITEM (USD / %) | FY 2025
FILED 2025-08-31 | FY 2024
FILED 2024-08-31 | FY 2023
FILED 2023-08-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.35B | $3.84B | $3.95B |
| YoY Revenue Growth % | +13.1% | -2.8% | — |
| Gross Profit | $2.08B | $1.78B | — |
| Gross Margin % | 47.8% | 46.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $563.9M | $553.3M | $473.4M |
| Operating Margin % | 13.0% | 14.4% | 12.0% |
| Net Income (GAAP) | $396.6M | $422.6M | $346.0M |
| EBITDA (Normalized) | $618.6M | $604.5M | $615.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $601.4M | $619.2M | $578.1M |
| Capital Expenditures (CapEx) | $68.4M | $64.0M | $177.8M |
| Free Cash Flow (FCF) | $533.0M | $555.2M | $400.3M |
| FCF Margin % | 12.3% | 14.5% | 10.1% |
| Return on Invested Capital (ROIC %) | 13.9% | 21.6% | 11.6% |
| Cash & Short-Term Equivalents | $376.1M | $935.6M | — |
| Total Debt (Short + Long Term) | $797.0M | $496.3M | $1.25B |
| Total Stockholders' Equity | $2.79B | $2.46B | $2.57B |